This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Cheol-Kyeung Kim: Innovator in Pharmaceutical Chemistry
Introduction
Cheol-Kyeung Kim is a notable inventor based in Namyangju-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug preparation. His work has led to advancements that benefit the pharmaceutical industry and improve therapeutic options.
Latest Patents
Cheol-Kyeung Kim holds a patent for a process titled "Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one." This invention describes a method for preparing pure 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one or a pharmaceutically acceptable salt thereof. The process is notable for its simplicity and high yield, utilizing a reaction between 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one and a 2-methylimidazole derivative in the presence of a halosilane compound.
Career Highlights
Cheol-Kyeung Kim is associated with Hanmi Pharm. Co., Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His expertise in chemical processes has positioned him as a valuable asset in the company, contributing to its reputation for quality and innovation in drug development.
Collaborations
Throughout his career, Cheol-Kyeung Kim has collaborated with esteemed colleagues, including Kwang-Ok Lee and Hee-Seock Kim. These partnerships have fostered a collaborative environment that enhances research and development efforts within the pharmaceutical sector.
Conclusion
Cheol-Kyeung Kim's contributions to pharmaceutical chemistry exemplify the impact of innovation in drug preparation processes. His patent and work at Hanmi Pharm. Co., Ltd. highlight his role as a key figure in advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
